Operating Lease, Right-of-Use Asset of RESMED INC from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
RESMED INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • RESMED INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $165,916,000, a 9.9% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

RESMED INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $165,916,000 +$14,904,000 +9.9% 31 Dec 2025 10-Q 30 Jan 2026 2026 Q2
Q3 2025 $162,007,000 +$4,939,000 +3.1% 30 Sep 2025 10-Q 31 Oct 2025 2026 Q1
Q2 2025 $167,497,000 +$16,376,000 +11% 30 Jun 2025 10-Q 30 Jan 2026 2026 Q2
Q1 2025 $152,603,000 +$5,528,000 +3.8% 31 Mar 2025 10-Q 24 Apr 2025 2025 Q3
Q4 2024 $151,012,000 -$2,461,000 -1.6% 31 Dec 2024 10-Q 31 Jan 2025 2025 Q2
Q3 2024 $157,068,000 +$33,652,000 +27% 30 Sep 2024 10-Q 25 Oct 2024 2025 Q1
Q2 2024 $151,121,000 +$23,166,000 +18% 30 Jun 2024 10-K 08 Aug 2025 2025 FY
Q1 2024 $147,075,000 +$19,567,000 +15% 31 Mar 2024 10-Q 26 Apr 2024 2024 Q3
Q4 2023 $153,473,000 +$25,251,000 +20% 31 Dec 2023 10-Q 25 Jan 2024 2024 Q2
Q3 2023 $123,416,000 -$1,903,000 -1.5% 30 Sep 2023 10-Q 27 Oct 2023 2024 Q1
Q2 2023 $127,955,000 -$4,359,000 -3.3% 30 Jun 2023 10-K 09 Aug 2024 2024 FY
Q1 2023 $127,508,000 -$13,665,000 -9.7% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q3
Q4 2022 $128,222,000 -$17,823,000 -12% 31 Dec 2022 10-Q 27 Jan 2023 2023 Q2
Q3 2022 $125,319,000 -$9,056,000 -6.7% 30 Sep 2022 10-Q 28 Oct 2022 2023 Q1
Q2 2022 $132,314,000 +$3,739,000 +2.9% 30 Jun 2022 10-K 11 Aug 2023 2023 FY
Q1 2022 $141,173,000 +$12,418,000 +9.6% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q3
Q4 2021 $146,045,000 +$14,754,000 +11% 31 Dec 2021 10-Q 28 Jan 2022 2022 Q2
Q3 2021 $134,375,000 +$9,902,000 +8% 30 Sep 2021 10-Q 29 Oct 2021 2022 Q1
Q2 2021 $128,575,000 +$10,227,000 +8.6% 30 Jun 2021 10-K 12 Aug 2022 2022 FY
Q1 2021 $128,755,000 +$2,478,000 +2% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q3
Q4 2020 $131,291,000 +$34,546,000 +36% 31 Dec 2020 10-Q 29 Jan 2021 2021 Q2
Q3 2020 $124,473,000 +$42,823,000 +52% 30 Sep 2020 10-Q 30 Oct 2020 2021 Q1
Q2 2020 $118,348,000 30 Jun 2020 10-K 17 Aug 2021 2021 FY
Q1 2020 $126,277,000 31 Mar 2020 10-Q 01 May 2020 2020 Q3
Q4 2019 $96,745,000 31 Dec 2019 10-Q 31 Jan 2020 2020 Q2
Q3 2019 $81,650,000 30 Sep 2019 10-Q 25 Oct 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.